RS
ResMed Inc.
RSMDF · OTC
$22.61 +0.00% (+$0.00)
1M -7.81%
Market Cap $32.8B
P/E Ratio 21.53x
Div. Yield 1.06%
ROE 23.88%
Bulios Fair Price
$13.78
39.1% downside
Current Price
$22.61
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RSMDF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
58 /100
Fair P/FCF 11.35x
P/E 21.53x
P/B 4.98x
Growth
86 /100
Growing FCF growth 43.41%
EPS growth 19.53%
Book val. growth 16.83%
Profitability
100 /100
Strong Op. margin 33.48%
Gross margin 61.16%
FCF margin 51.11%
Quality
91 /100
Excellent ROA 16.99%
ROIC 19.11%
Asset turnover 0.63x
Debt
100 /100
Low Int. coverage 67.12x
Debt/Equity 0.13x
Net debt/EBITDA -0.30x
Stability
100 /100
Stable EPS volatility 15.12%
Beta 0.75x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RSMDF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael J. Farrell
Employees
11,370
Headquarters
San Diego
Upcoming events
22 OCT
Earnings
Upcoming earnings report